Amphix Bio | $12,500,000 | (Dec 19, 2025)
arcads AI | $16,000,000 | (Dec 19, 2025)
Katalist | $1,500,000 | (Dec 19, 2025)
Xelix
United Kingdom
- London, England
- 22/07/2025
- Series B
- $160,000,000
Overview
Since 2018, we have pioneered the Accounts Payable audit and controls space. Our AI-powered platform seamlessly integrates with existing ERP and finance systems to detect payment errors and fraud, automate statement reconciliations, and streamline AP Helpdesk operations. Trusted by global enterprises like AstraZeneca, BAT, and Virgin Atlantic, we process over 115 million invoices annually and audit more than $750 billion in spend.
Our mission is to help finance teams reduce risk, unlock significant cost savings, and elevate AP from a manual, back-office function to a strategic, data-driven business partner. As category leaders, we set a new standard in finance operations by delivering outstanding ROI, providing exceptional customer support, and leveraging best-in-class AI and agentic workflows that redefine industry benchmarks.
- Industry Software Development
- Website https://xelix.com/
- LinkedIn https://www.linkedin.com/company/xelix./
Related People
Paul RoiterCo Founder
United Kingdom -
Greater London, England
Co-Founder of Xelix - a AI SaaS solution providing Accounts Payable controls to some of the largest companies in the world.
Ambitious company builder.
Syremis Therapeutics | $165,000,000 | (Dec 19, 2025)
Gravity Labs Co., Ltd. | $17,000,000 | (Dec 19, 2025)
Edison Scientific | $70,000,000 | (Dec 19, 2025)
InfiniteWatch | $4,000,000 | (Dec 19, 2025)
Thread | $18,000,000 | (Dec 19, 2025)
Neural Concept | $100,000,000 | (Dec 19, 2025)
SkillCorner | $60,000,000 | (Dec 19, 2025)
Wearlinq | $14,000,000 | (Dec 18, 2025)
T-CURX GmbH | $20,000,000 | (Dec 18, 2025)